Quest Diagnostics, Secaucus, NJ, has launched a new suite of return-to-work services developed to perform large-scale workforce testing for covid-19. The services are designed to help organizations access and act on covid-19 laboratory insights in order to foster safer workplace environments for their employees as the nation begins to restart the US economy. The Quest Diagnostics return-to-work services feature access to covid-19 diagnostic and antibody testing and related capabilities.
Steve Rusckowski, Quest Diagnostics.
“All of us are eager to get back to work as safely as possible, and covid-19 testing is essential to making this happen,” says Steve Rusckowski, chairman, chief executive officer, and president of Quest Diagnostics. “Quest has been at the forefront of covid-19 testing, and our return-to-work solution is informed by this experience as well as our leadership in population health services for employers across the country.”
To accommodate expected demand, Quest Diagnostics is scaling up its covid-19 lab operations. The company has capacity to perform approximately 200,000 antibody tests per day, and it expects to have capacity to perform approximately 150,000 molecular diagnostic tests per day by the end of June.
Jay G. Wohlgemuth, MD, Quest Diagnostics.
“Every workforce has different testing needs, depending on the local environment, the type of work, the work environment, and interactions with customers for the job category,” says Jay G. Wohlgemuth, MD, senior vice president and chief medical officer and head of Quest’s employer population health business. “Our return-to-work solution can be tailored to each organization’s unique requirements.”
In addition to testing, Quest’s return-to-work services include:
- Event hosting, with onsite temperature checks and respiratory and blood specimen collection by trained Quest Diagnostics staff.
- Access to multiple specimen collection options, ranging from respiratory specimen collection for diagnostic testing to use of the company’s 2,200 patient service centers for blood draws in conjunction with covid-19 antibody testing.
- IT solutions that include secure online help to direct participants to appropriate testing (diagnostic or antibody), based on factors such as symptoms and exposure to sick individuals, and easy-to-understand results reporting.
- Access to physician ordering, oversight, and telemedicine services.
- Data integrated with contact tracing and infection control software applications in use by employers.
- Influenza vaccination services, which will ultimately be incorporated with SARS CoV-2 vaccines, when available.
“Some jobs are higher risk than others, and we plan to prioritize testing access for organizations that employ healthcare workers, first responders, and others whose health and safety are critical to our nation’s response to covid-19,” says Wohlgemuth.
For more information, visit Quest Diagnostics.
